Skip to content
Screener

NeoGenomics NEO Q3 2025 earnings

Reported October 28, 2025 · Before market open

Revenue$187.8MMiss by $448.6K
EPS$0.03Beat by $0.01
Revenue estimate$188.2M
EPS estimate$0.02

Next report

Oct 27, 2026 (in a month)
Revenue estimate$205.9M
EPS estimate$0.06

Financials

Q3 2025

Income statement

See full
Revenue$187.8M+11.9%
Gross profit$80.4M+7.4%
Operating income-$27.0M-27.4%
Net income-$27.1M-53.3%
EPS (diluted)-$0.21-50.0%

Balance sheet

See full
Cash & equivalents$164.1M-54.7%
Total debt$68.8M+4.5%
Total equity$838.3M-7.7%
Total assets$1.4B-16.2%

Cash flow

See full
Operating cash flow$8.9M—
CapEx$8.3M-23.0%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$997.26M-46.5%
Enterprise value$901.97M-42.5%
P/S1.4×-1.5×

Profitability

See full
Gross margin43.5%-0.1pp
Operating margin-17%+4.0pp
Net margin-16%+7.7pp

Returns & leverage

See full
Return on equity-13%+15.9pp
Debt / equity0.1×0.0×
Current ratio3.9×+1.9×

Segments

By product

See full
Client direct billing$132.3M+32.8%
Commercial insurance$32.5M+31.6%
Self-pay$69.0K-68.3%

By segment

See full
Reportable Segment$187.8M—

FAQ

When did NeoGenomics report Q3 2025 earnings?
NeoGenomics (NEO) reported Q3 2025 earnings on October 28, 2025 before market open.
What were NeoGenomics's Q3 2025 revenue and EPS?
NeoGenomics reported revenue of $187.8M and eps of $0.03 for Q3 2025.
Did NeoGenomics beat estimates in Q3 2025?
Revenue missed the consensus estimate of $188.2M by $448.6K. EPS beat the consensus estimate of $0.02 by $0.01.
How did NeoGenomics's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 11.9% from $167.8M a year earlier and eps declined 40.0% from $0.05.
Where can I find NeoGenomics's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001077183-25-000172) and the 10-Q periodic report (0001077183-25-000175) directly on SEC EDGAR. The filing index links above go to sec.gov.